257 research outputs found
Can platelet-rich plasma be an alternative to surgery for resistant chronic patellar tendinopathy in sportive people? Poor clinical results at 1-year follow-up
Introduction and purpose: Patellar tendinopathy is a disease affecting particularly athletes. Platelet-rich plasma (PRP) injections have gained increasing interest for their potential benefits. Anyway, a tendon disease longer than 6 months should be considered as an indication for surgery. The aim of our study was to evaluate the efficacy of PRP in athletes with a severe chronic patellar tendinopathy longer than 6 months when surgery should be chosen. Methods: We enrolled 17 sport practitioners (19 patellar tendons) who did not want to undergo surgery and who are nonresponders to other conservative treatments. We treated them with PRP and calculated the results using the visual analog scale (VAS), the Victorian Institute of Sport Assessment-Patellar (VISA-P) score, and Tegner Activity Scale. Every test has been conducted at T0, T1 (4 months), and T2 (12 months). Results: We found a poor improvement at T1 and a clinical worsening at T2 through VAS. VISA-P showed a medium improvement both at T1 and T2. Tegner scale did not show improvements. Conclusions: Our study was not able to remove the doubts about the benefits of PRP in patellar tendinopathy, confirming ambiguous certainties. Further investigations are needed to assess its effectiveness
Tablet splitting in elderly patients with dementia: The case of quetiapine
Quetiapine is an atypical antipsychotic approved for treating schizophrenia, bipolar depression, and mania but is frequently used in an off-label manner to control the behavioral and psychological symptoms of dementia in elderly patients with dementia. Due to the need to personalize doses for elderly patients with dementia, quetiapine tablet manipulation is widespread in hospital settings, long-term care facilities, and patient homes. The aim of this study was to assess the impact of the different splitting techniques on quetiapine fumarate tablets by analysing the obtained sub-divided tablets and to discuss compliance with the European Pharmacopoeia limits on whole and split tablets. Quetiapine fumarate tablets of two dose strengths were taken at random (in a number able to assure a power of 0.8 during statistical comparison) and were split with a kitchen knife or tablet cutter. The weight and the drug content were determined for each half tablet. The obtained data were compared to the European Pharmacopoeia limits. The differences between the different splitting techniques were statistically tested. Data showed that split tablets, independently of the dose strength and the technique employed, were not compliant with the European Pharmacopoeia specifications for both entire and subdivided tablets in terms of weight and content uniformity. Thus, such a common practice could have potential effects on treatment efficacy and toxicity, especially when also considering the fragility of the elderly target population in which polypharmacotherapy is very common. These results indicate a compelling need for flexible quetiapine formulations that can assure more accurate dose personalization
ASTHMA AND MAST CELL BIOLOGY
Asthma is a chronic inflammatory disease of the lung and its pathophysiology is initiated by mast cell
activation in response to the antigen binding to IgE receptor as well as by TH2 cell activation. Mast cells
are well established effector cells in asthma where they exacerbate the inflammatory response, playing a
key role in early phase, degranulating and increasing histamine. Human mast cells possess high affinity
IgE receptors and are ubiquitous but predominantly localized in mucosal and connective tissue and are
distributed along blood vessels. There are two types of mast cells: connective tissue mast cells (TC) and
mucosal mast cells (T mast cells). TC mast cells contain more heparin, whereas T mast cells contain
more chondroitin sulfate. In asthma, mast cell activation can trigger degranulation, releasing secretory
granule complex and preformed mediators, such as histamine and proteases, along with the synthesis of
leukotrines and prostaglandins, and induction of cytokines and chemokines. Leukotrine inhibitors and
omalizumab, which inhibits IgE, both relieve the asthma exacerbation when administered to humans
and permit to reduce the use of other drugs. The release of cytokines by mast cells, such as TNF-alpha, IL-1, IL-6 and IL-33, participate in the pathogenesis of asthma. Stress worsens asthma, and this effect
is also mediated by mast cell activation through the release of cytokines. Administration of IL-33 in
experimental animals provokes pathological effects in the mucosal tissues and augments antibody IgE
and IgA in blood vessels. Here, we report the impact of mast cell biology in asthma pathogenesis
Características dos primeiros híbridos de canola com tecnologia para controle de plantas daninhas, no Brasil.
Estratégias de sucessão trigo/aveia preta-soja para sistemas de produção de grãos no Noroeste do Rio Grande do Sul.
bitstream/item/144791/1/ID43666-2016CTO29.pd
Características agronômicas e rendimento de grãos de genótipos de canola em Três de Maio, RS, 2015.
Melhoramento de soja para alimentação humana na Embrapa Trigo - safra agrícola 2014/2015.
bitstream/item/141066/1/ID43630-2015PLDocOnline155sojaresultadosp25.pd
Comportamento de Genótipos de Girassol nas Safras 2013/14 e 2014/15.
bitstream/item/154743/1/Circular-174.pd
Melhoramento de soja para alimentação humana na Embrapa Trigo - safra agrícola 2015/2016.
bitstream/item/147718/1/ID43759-2016DO161p25.pd
Adaptabilidade e estabilidade de híbridos de girassol para as condições de safra brasileira.
bitstream/item/208135/1/Boletim-329.pd
- …